Lv1
30 积分 2024-04-11 加入
A Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis
11小时前
待确认
简体中文版皮肤病生活质量指标信度和效度初探
2天前
已关闭
Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies
21天前
已完结
27716 Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline clinical characteristics: Pooled subgroup analysis from two randomized phase 3 studies
21天前
已完结
Safety and Efficacy of ICP-332 for Moderate to Severe Atopic Dermatitis: A Phase 2 Randomized Clinical Trial
22天前
已关闭
Recent advances in universal chimeric antigen receptor T cell therapy
2个月前
已完结
碱性成纤维细胞生长因子对深二度烧伤患者的安全性和有效性
3个月前
已完结
CDK4/6抑制剂后时代下的乳腺癌精准诊疗
6个月前
已完结
小细胞肺癌靶向药物治疗进展
6个月前
已完结
皖公网安备34019202002308
